Cite
O2-2-3 [Encore] Phase II trial of GEMOX for the advanced pancreatic cancer with family/personal history of HBOC related cancer.
MLA
Tsumura, Hidetaka, et al. “O2-2-3 [Encore] Phase II Trial of GEMOX for the Advanced Pancreatic Cancer with Family/Personal History of HBOC Related Cancer.” Annals of Oncology, vol. 30, Oct. 2019, p. N.PAG. EBSCOhost, https://doi.org/10.1093/annonc/mdz339.017.
APA
Tsumura, H., Morizane, C., Nomura, S., Takahashi, H., Okano, N., Mizuno, N., Satake, H., Tsuji, K., Shioji, K., Asagi, A., Yasui, K., Miyakawa, H., Ishiguro, A., Ogura, T., Ueno, M., Tobimatsu, K., Terashima, T., Ikeda, M., Okusaka, T., & Furuse, J. (2019). O2-2-3 [Encore] Phase II trial of GEMOX for the advanced pancreatic cancer with family/personal history of HBOC related cancer. Annals of Oncology, 30, N.PAG. https://doi.org/10.1093/annonc/mdz339.017
Chicago
Tsumura, Hidetaka, Chigusa Morizane, Shogo Nomura, Hideaki Takahashi, Naohiro Okano, Nobumasa Mizuno, Hironaga Satake, et al. 2019. “O2-2-3 [Encore] Phase II Trial of GEMOX for the Advanced Pancreatic Cancer with Family/Personal History of HBOC Related Cancer.” Annals of Oncology 30 (October): N.PAG. doi:10.1093/annonc/mdz339.017.